Skip to main navigation
Better Therapeutics Receives FDA Authorization to Treat Adults with Type 2 Diabetes
logo
  • Overview
  • News & Events
    • Press Releases
    • Presentations & Events
  • Stock
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Governance
    • Documents & Charters
    • Board of Directors
    • Leadership
    • Committee Composition
    • Financial Concern Hotline
    • Code of Conduct Hotline
  • Financials
    • SEC Filings
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact

Event Details

Better Therapeutics Second Quarter 2023 Business Update Call

Aug 9, 2023 | 4:30 PM EDT

Click here for webcast

Supporting Materials

Better Therapeutics Q2 2023 Earnings 5.7 MB
Better therapeutics black bg - no clear space

Investor Relations

News & Events Press Releases Presentations & Events
Stock Stock Quote & Chart Historic Price Lookup Investment Calculator Analyst Coverage
Governance Documents & Charters Board of Directors Leadership Committee Composition Financial Concern Hotline Code of Conduct Hotline
Financials SEC Filings
Investor Resources Investor FAQs Email Alerts Contact
© Better Therapeutics, Inc       

Footer Terms Policy Links

Terms      Privacy     

Footer Social Links

Facebook Instagram LinkedIn Twitter
x
Exit

You are leaving Better Therapeutics, Inc. website. You may return to Better Therapeutics, Inc. website by using the back button on your web browser toolbar or closing the window to the third-party website that you have opened. Do you wish to continue?

YES NO